Minimize the risk of stroke during your TAVR procedure
COVID-19 has brought unprecedented challenges to healthcare systems. If your transcatheter aortic valve replacement (TAVR) procedure has been delayed, we know that may have caused frustration and confusion for you or your loved ones. Severe aortic stenosis is a serious condition that requires timely treatment, so be sure to continue talking with your heart team and follow their advice. Find out what experts are saying here.
If you have severe aortic stenosis, your heart team may recommend transcatheter aortic valve replacement (TAVR) to treat the condition. During the aortic valve replacement procedure, pieces of the calcified heart valve, or other debris, can break loose and travel through the arteries toward the brain. This material is called embolic debris. If left unaddressed, the debris could cause blockages, potentially leading to stroke.
To help protect patients from the risk of a stroke during TAVR, medical centers are beginning to offer Protected TAVR using the SENTINELTM Cerebral Protection System (CPS).
The SENTINEL Cerebral Protection System (CPS) is designed to capture embolic debris and to help protect you from the risk of stroke. Learn more about Protected TAVR with SENTINEL cerebral embolic protection.
Dr. Jim McCutchon, a retired urologist, learned he needed to have a Transcatheter Aortic Valve Replacement (TAVR) procedure. After researching the benefits and potential risks with TAVR, Dr McCutchon found a center where he could get SENTINEL Cerebral Protection.
Why consider cerebral embolic protection?
To these cardiologists, the question isn’t “Why you would want Protected TAVR — it’s why wouldn’t you?” Hear the experts’ opinions on why cerebral embolic protection is important for you.
Reduce your risk of stroke with Protected TAVR
The SENTINEL Cerebral Protection System (CPS) is the first and only device in the U.S.to help protect you from the risk of stroke during TAVR. It works by capturing and removing embolic debris dislodged during TAVR, before it can reach the brain.
Clinical studies show that patients who undergo TAVR with the SENTINEL CPS have a significant reduction in stroke as compared to patients who undergo TAVR without cerebral embolic protection.
As with any medical device, there are risks associated with use of the SENTINEL Cerebral Protection System. These risks include but are not limited to: infection, blood vessel injury, stroke, death.
Issues specific to the use of the SENTINEL have been reported in a small number of patients and typically went away in 30 days. The use of SENTINEL during yourprocedure is solely at the discretion of your doctor.
1 Source: SENTINEL Clinical Trial